Singular Genomics Systems, Inc.
(NASDAQ CM: OMIC)
Rigrodsky Law, P.A. is investigating Singular Genomics Systems, Inc. (“Singular Genomics”) regarding possible breaches of fiduciary duties and other violations of law related to Singular Genomics’ agreement to be acquired by an affiliate of Deerfield Management Company, L.P. Under the terms of the agreement, Singular Genomics shareholders will receive $20.00 per share in cash.